Neuroendocrine tumors originate from neuroendocrine cells, often presenting as slower-growing compared to other cancers like ...

The Somatostatin Analogs Market growth is driven by rising cases of NETs, acromegaly, and Cushing’s disease along with strong R&D investment.Austin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Somatostatin ...

Patients with diabetes have high blood glucose levels either because their pancreas does not produce sufficient insulin, or their body cells do not respond to signals from insulin that tell them to ...

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. This has been shown by a study conducted at, among others, the ...

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. The proposed strategy is said to have the potential to save lives.

Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Updated results of a randomized, double-blind, placebo-controlled, multicenter, phase III trial (RADIANT-3). Everolimus ...

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. This has been shown by a study conducted at, among others, the ...